Page last updated: 2024-08-26

equol and Adenocarcinoma, Endometrioid

equol has been researched along with Adenocarcinoma, Endometrioid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Doerge, DR; Helferich, WG; Ju, YH; Katzenellenbogen, BS; Katzenellenbogen, JA; Muthyala, RS; Sheng, S; Williams, LD	1

Other Studies

1 other study(ies) available for equol and Adenocarcinoma, Endometrioid

Article	Year
Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorganic & medicinal chemistry, 2004, Mar-15, Volume: 12, Issue:6 Topics: Antineoplastic Agents; Binding Sites; Carcinoma, Endometrioid; Chromatography, High Pressure Liquid; Equol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Female; Genistein; Glycine max; Humans; Isoflavones; Phytoestrogens; Phytotherapy; Plant Preparations; Receptors, Estrogen; Tumor Cells, Cultured	2004

Article

Year

Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.

Bioorganic & medicinal chemistry, 2004, Mar-15, Volume: 12, Issue:6

Topics: Antineoplastic Agents; Binding Sites; Carcinoma, Endometrioid; Chromatography, High Pressure Liquid; Equol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Female; Genistein; Glycine max; Humans; Isoflavones; Phytoestrogens; Phytotherapy; Plant Preparations; Receptors, Estrogen; Tumor Cells, Cultured

2004